Independent analysis of AML patients (n = 154) based on The Cancer Genome Atlas (TCGA) dataset confirmed a significant positive correlation between high RNF5 expression (10%) and poor survival (P = 0.009, Fig. 1e). The gene discussed is RNF5; the disease is acute myeloid leukemia.